Glabellar Frown Lines
📧 Sign up to get email alerts when something new happens for Glabellar Frown Lines.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101) [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of CU-20101 Botulinum toxin Type A for injection in treating glabellar frown lines has co…
-
CLINICAL_TRIALS trial_result · 2025-05-07Clinical Trial Update: A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines [Phase 3]
Phase 3 non-inferiority trial comparing AbobotulinumtoxinA from Espad Pharmed with Dysport for correction of moderate to severe glabellar li…
-
CLINICAL_TRIALS trial_result · 2024-03-27Clinical Trial Update: Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines [Phase 3]
Phase 3 clinical trial evaluating QM1114-DP for aesthetic improvement in moderate to severe glabellar frown lines and lateral canthal lines …
-
CLINICAL_TRIALS trial_result · 2024-02-22Clinical Trial Update: Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines [Phase 2]
Phase 2 clinical trial assessing safety and efficacy of Botulinum Toxin Type A for treating glabellar lines has been completed with results …
-
CLINICAL_TRIALS trial_result · 2024-02-16Clinical Trial Update: Study Comparing Treatment With Alluzience vs Reconstituted Toxin [Phase 4]
A phase 4 trial comparing Alluzience with reconstituted toxin for treatment of glabellar frown lines has completed with results posted in 20…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-16Clinical Trial Update: Long-term Extension Study to Evaluate MBA-P01 in Subjects With Moderate to Severe Glabellar Lines [Phase 3]
A long-term extension phase 3 trial evaluating MBA-P01 for moderate to severe glabellar lines has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines [Phase 3]
Phase 3 study comparing Protoxin to Botox in adults with moderate to severe glabellar lines has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination [Phase 3]
Phase 3 clinical trial update for treatment of moderate to severe lateral canthal lines and glabellar lines, alone or in combination, comple…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Treatment of Moderate to Severe Glabellar Lines [Phase 3]
Phase 3 trial update for treatment of moderate to severe glabellar lines has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Lines [Phase 2]
A Phase II clinical trial evaluating the efficacy and safety of MBA-P01 in adults with moderate to severe glabellar lines has been completed…
-
CLINICAL_TRIALS trial_result · 2023-02-03Clinical Trial Update: Study to Compare the Efficacy and Safety of ATGC-110 (Botulinum Toxin) With Xeomin® for the Treatment of Moderate to Severe Glabellar Frown Lines [Phase 3]
Phase 3 trial comparing ATGC-110 botulinum toxin with Xeomin for moderate to severe glabellar frown lines.
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines [Phase 2]
Phase 2 trial assessing safety and efficacy of botulinum toxin for glabellar frown lines has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: A Safety and Efficacy Study of Different Injections Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines [Phase 4]
Phase 4 trial evaluating safety and efficacy of different injection volumes of Botulinum Toxin Type A (Azzalure) for glabellar lines; comple…
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines [Phase 3]
Phase 3 trial results for daxibotulinumtoxinA for injection show efficacy and safety in treating moderate to severe glabellar lines, with co…
-
CLINICAL_TRIALS trial_result · 2022-06-03Clinical Trial Update: Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of MBA-P01 in treating glabellar frown lines has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines [Phase 3]
Phase 3 trial update on the efficacy and safety of botulinum toxin for moderate to severe glabellar lines has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines [Phase 1, Phase 2]
A completed clinical trial update for PROTOXIN evaluating safety and efficacy in subjects with moderate to severe glabellar lines across Pha…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines [Phase 3]
Phase 3 trial evaluating efficacy and safety of a new dilution and injection volume of abobotulinumtoxinA for glabellar lines has completed …
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines [Phase 2]
Phase 2 clinical trial evaluating MBA-P01 for efficacy and safety in treating glabellar lines has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Long-term Safety and Efficacy of MEDITOXIN® in Treatment Glabellar Lines [Phase 4]
Phase 4 trial update on long-term safety and efficacy of MEDITOXIN® for glabellar lines.
-
CLINICAL_TRIALS trial_result · 2020-07-29Clinical Trial Update: The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines [Phase 3]
Phase 3 trial update on the efficacy and safety of CUNOX® in adults with moderate to severe glabellar lines.
-
CLINICAL_TRIALS trial_result · 2020-07-28Clinical Trial Update: Long-term Open-label Treatment of Moderate to Severe Glabellar Lines With CORETOX® [Phase 4]
A Phase 4 open-label trial evaluating long-term treatment of moderate to severe glabellar lines with CORETOX.
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: A Comparative Study of Botulinum Neurotoxin Type A in Treatment of Moderate to Severe Glabellar Frown Lines [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating Botulinum Neurotoxin Type A for moderate to severe glabellar frown lines.
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Subject Satisfaction With AbobutulinumtoxinA Treatment [Phase 4]
A Phase 4 clinical trial assessing patient satisfaction with AbobutulinumtoxinA for glabellar frown lines has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: Efficacy and Safety Study of MT10107 in the Treatment of Glabella Line [Phase 3]
Phase 3 trial update on MT10107 for treatment of glabellar frown lines, reporting efficacy and safety data.